MYLAN 2268 MYLAN 2268 (Terazosin 5 mg)

Pill imprint MYLAN 2268 MYLAN 2268 has been identified as Terazosin hydrochloride 5 mg.

Terazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; hyperhidrosis and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy. Terazosin 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for MYLAN 2268 MYLAN 2268

Terazosin hydrochloride 5 mg MYLAN 2268 MYLAN 2268
Terazosin hydrochloride
Imprint:
MYLAN 2268
MYLAN 2268
Strength:
5 mg
Color:
Gray & Pink
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-2268
Inactive Ingredients:
lactose anhydrous
silicon dioxide
D&C Red No. 28
D&C Red No. 33
FD&C Blue No. 1
gelatin
magnesium stearate
microcrystalline cellulose
corn starch
sodium lauryl sulfate
titanium dioxide
ferrosoferric oxide
D&C Yellow No. 10
FD&C Blue No. 2
FD&C Red No. 40
propylene glycol
shellac
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0938 UDL Laboratories Inc
54569-4875 A S Medication Solutions LLC (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web4)